Skip to main page content

Gus Gazzard

Keynote Speaker
Participates in 4 items

Professor of Ophthalmology at UCL and Director of the Moorfields Glaucoma Service
Prof. Gus Gazzard was made a Consultant in the Glaucoma Service at Moorfields Eye Hospital in 2009 after a Clinical Fellowship at Moorfields 2006-08 and a Research Fellowship with Prof Peng Khaw. when he ran the 6-year Singapore-5FU surgical trial and was awarded his research degree for a thesis on angle-closure glaucoma.  He is Chief Investigator of the 6-year (£2.5m) multi-centre LiGHT trial of SLT and co-investigator on the NEI-funded ($15.2m) COAST and NIHR-funded (£2m) NAMING randomized controlled trials of glaucoma therapies.

Academic Appointments
Professor of Ophthalmology (Glaucoma Studies), Institute of Ophthalmology, UCL   2019-present

Non-Academic Appointments
Consultant Ophthalmic Surgeon & Glaucoma Service Director, Moorfields Eye Hospital, NHS Trust, London UK       2009-present

 MD University College London 2005
 FRCOphth Royal College of Ophthalmologists 1997
 MA MBBChir Corpus Christi College, Cambridge University 1988-1995

Financial disclosure: Dr Gazzard has/had an affiliation (financial or otherwise) with a commercial organization:

  1. Alcon, 
  2. Allergan, 
  3. B&L, 
  4. Belkin,
  5. Ellex, 
  6. Equinox, 
  7. Genentech, 
  8. Glaukos, 
  9. Haag-Streit, 
  10. Heidelberg, 
  11. Ivantis, Lumenis, 
  12. McKinsey, 
  13. Merck/MSD, 
  14. Pfizer, 
  15. Reichert, 
  16. Santen, 
  17. Sight Science, 
  18. Thea


Sessions in which Gus Gazzard participates